Literature DB >> 22471970

Role of human papillomaviruses in persistent and glucocorticoid-resistant juvenile phimosis.

A Pilatz1, B Altinkilic, A Rusz, N Izykowski, W Traenkenschuh, J Rische, U Lehmann, C Herbst, L Maegel, J Becker, W Weidner, D Jonigk.   

Abstract

BACKGROUND: In adults, human papillomaviruses (HPV), lichen sclerosus et atrophicus (LSA) and phimosis are considered to be major risk factors for penile cancer. In boys, a possible association between phimosis, LSA and HPV has been suggested.
OBJECTIVE: To investigate the role of HPV in the persistence of phimosis in children. PATIENTS AND METHODS: Out of a cohort of 420 boys presenting with foreskin problems, we prospectively sampled the preputial tissue of 82 patients during circumcision: 46 with steroid-naïve and 36 with steroid-resistant phimosis. All foreskins were assessed clinically and histopathologically with regard to appearance, inflammation, oedema, epithelial degeneration and fibrosis. The viral status of the foreskins was determined by immunohistochemistry and highly sensitive PCR, with subsequent subtyping by DNA hybridization (HPV types 6, 11, 16, 18, 31, 33, 35, 39, 42, 44, 45, 51-54, 56, 58, 59, 61, 62, 66-68, 70, 72, 73, 81-84, 90, 91).
RESULTS: The foreskins appeared normal in 62 boys and suggestive of LSA in one single case. Small cracks or white scars were present in seven steroid-naïve and 12 steroid-resistant foreskins. LSA was diagnosed microscopically in two of the steroid-naïve and six of the steroid-pretreated group. No evidence of HPV was found in any of the juvenile foreskins.
CONCLUSIONS: Our prospective study has provided evidence that HPV is not usually present in the foreskin of boys with persistent phimosis after their first year of life and that topical glucocorticoid treatment failure is not associated with HPV or any specific histopathological changes.
© 2012 The Authors. Journal of the European Academy of Dermatology and Venereology © 2012 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22471970     DOI: 10.1111/j.1468-3083.2012.04542.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  7 in total

1.  Expression analysis of leukocytes attracting cytokines in chronic histiocytic intervillositis of the placenta.

Authors:  Lukas Freitag; Constantin von Kaisenberg; Hans Kreipe; Kais Hussein
Journal:  Int J Clin Exp Pathol       Date:  2013-05-15

2.  Expression of caspase 14 and filaggrin in oral squamous carcinoma.

Authors:  Constance Scharenberg; André Eckardt; Christina Tiede; Hans Kreipe; Kais Hussein
Journal:  Head Neck Pathol       Date:  2013-05-04

Review 3.  Male genital lichen sclerosus.

Authors:  Christopher Barry Bunker; Tang Ngee Shim
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

Review 4.  Penile Lichen Sclerosis: A Surgical Perspective of its Aetiology and Treatment.

Authors:  Dhiraj Bhambhani; Suresh Bhambhani; Nitin Kumar Pandya
Journal:  Cureus       Date:  2022-08-26

5.  Is real-time PCR the correct method to evaluate the incidence of human papillomavirus in prepuces of asymptomatic boys and men?

Authors:  Isabel Heidegger; Renate Pichler; Barbara Müller; Helmut Klocker; David Oswald; Bernhard Haid; Bettina Zelger; Wolfgang Horninger; Josef Oswald
Journal:  World J Urol       Date:  2013-10-22       Impact factor: 4.226

6.  Expression of cyclin-dependent kinase inhibitor 2A 16, tumour protein 53 and epidermal growth factor receptor in salivary gland carcinomas is not associated with oncogenic virus infection.

Authors:  Ellen Senft; Juliana Lemound; Angelika Stucki-Koch; Nils-Claudius Gellrich; Hans Kreipe; Kais Hussein
Journal:  Int J Oral Sci       Date:  2015-03-23       Impact factor: 6.344

7.  HPV prevalence in the foreskins of asymptomatic healthy infants and children: Systematic review and meta-analysis.

Authors:  Bora Lee; Sang Wook Lee; Dae In Kim; Jae Heon Kim
Journal:  Sci Rep       Date:  2017-08-01       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.